CVIR Endovascular is a multidisciplinary open access journal of the Cardiovascular and Interventional Radiological Society of Europe and the first open peer-review journal in the field of endovascular interventions. The journal is intended for ALL specialists working in the field of endovascular treatment.
CVIR Endovascular publishes manuscripts in the area of venous and arterial interventions including vascular malformations, non-oncological embolisation, peripheral vascular interventions, aortic interventions, emergency medicine and carotid interventions.
CVIR Endovascular publishes a range of manuscript types including clinical investigations, systematic reviews, case reports, technical reports and video cases. The field of endovascular treatment is very dynamic and new ideas need rapid communication so that the latest information is available to treat our patients. CVIR Endovascular also wants to stimulate scientific discussions and provides a podium to discuss your research work with your peers.
CVIR Endovascular is part of the CVIR journal family, together with CardioVascular and Interventional Radiology (CVIR). CVIR is the oldest journal in the field of Interventional Radiology and the international journal for interventional radiology.
Prof. Jim A. Reekers is a Professor of Radiology and Interventional Radiology at the University of Amsterdam. He is well-known in IR circles and has been a driving force in CIRSE, serving as president of the society from 2007 to 2009. A pioneer of subintimal angioplasty, Prof. Reekers has also developed numerous techniques, catheters and filters. But perhaps his most important contribution to IR has been his untiring efforts to establish IR as an evidence-based and clinical trial-driven discipline. Prof. Reekers has authored more than 150 peer-reviewed publications and 22 book chapters. His research interest is critical limb ischemia, especially in diabetic disease and included both imaging and treatment.
Words from From the Editor-in -Chief, Prof. Jim A. Reekers
Endovascular treatment is a multidisciplinary profession which is producing a constant stream of new technologies and scientific publications. Interventional radiologists, vascular surgeons, cardiologists and angiologists are all active in this field. There are several models of how physicians in these fields work individually or as a team.
The developments in endovascular treatment are presented at an exceptional pace, whether that be through modifications of existing technologies or completely new pathways. Fast communication without borders and hurdles is therefore needed, and open access is the way forward. Currently, the few existing vascular surgery or interventional radiology journals only have limited space for endovascular publications. With this limited space, it is unavoidable that many good papers are rejected. Also, over 90% of case reports and technical notes that are not only interesting, but vital to the work we do, are being rejected.
CVIRendovascular was created as a platform to publish papers focused on endovascular treatment and to communicate to the endovascular community through a constant stream of publications.
Discussions among peers have been fundamental to the development of endovascular treatment. We would like to keep this tradition alive by opening, together with the journal, a discussion platform for the whole endovascular community.
CVIRendovascular seeks to facilitate an environment of engaging with, learning from, and questioning your peers.
A fast and effective peer review process, in line with the characteristics of the endovascular attitude, will ensure a rapid appraisal of manuscripts. The CVIRendovascular Editorial Board has been formed thanks to the availability of skilled and enthusiastic experts in endovascular treatment.
The Open Access model of the journal offers a fast and reliable way to disseminate knowledge and can be supported with several funding schemes in case authors are in need of resources for article publication.
Besides original articles, CVIRendovascular is aimed at publishing case reports, technical notes, reviews and short communications. Comments and ideas can be shared within the scientific community through Editorials and Letters to the Editor.
We are confident CVIRendovascular will actively contribute to creating a bridge between different modalities that are in charge of endovascular treatment and
will facilitate their use in the scientific community.
Jim A. Reekers
Robert Morgan, St. George's Hospital, London, UK
Fabrizio Fanelli, Sapienza University of Rome, Rome, Italy
Jafar Golzarian, University of Minnesota, Minneapolis, USA
Mohamad Hamady, Imperial College London, London, UK
Andrew Holden, Auckland City Hospital, Auckland, New Zealand
Konstantinos Katsanos, Guy's and St. Thomas' Hospitals, London, UK
Ian McCafferty, Queen Elizabeth Hospital Birmingham, Birmingham, UK
Joo-Young Chun, Barts Health NHS Trust, London, UK
Diederick de Boo, Alfred Health, Essendon, Australia
Michiel W. de Haan, University Hospital Maastricht, Maastricht, Netherlands
Peter Huppert, Municipal Hospital Darmstadt, Darmstadt, Germany
Christian Loewe, Medical University of Vienna, Vienna, Austria
Mariano Palena, Policlinico Abano Terme, Abano Terme, Italy
Lakshmi Ratnam, St. George's Hospital, London, UK
Stavros Spiliopoulos, Attikon University Hospital, Athens, Greece
Maria Tsitskari, Attikon University Hospital, Athens, Greece
Vinko Vidjak, KB Merkur, Zagreb, Croatia